S. Loukides (Athens, Greece), A. Bikov (Budapest, Hungary)
Late Breaking Abstract - ENose based phenotyping of newly presented patients with asthma or COPD R. de Vries (Amsterdam, Netherlands), Y. Dagelet (Amsterdam, Netherlands), S. Kester (Den Bosch, Netherlands), J. In 'T Veen (Rotterdam, Netherlands), E. Haarman (Amsterdam, Netherlands), A. Lucas (Eindhoven, Netherlands), F. De Jongh (Enschede, Netherlands), A. Maitland-Van Der Zee (Amsterdam, Netherlands), P. Sterk (Amsterdam, Netherlands)
|    |
U-BIOPRED accessible handprint: combining omics platforms to identify stable asthma subphenotypes B. De Meulder (Lyon, France), R. Tching Chi Yen (Lyon, France), C. Li (Stockholm, Sweden), A. Wheelock (Stockholm, Sweden), K. Chung (London, United Kingdom), I. Adcock (London, United Kingdom), R. Djukjanovic (Southampton, United Kingdom), S. Wagers (Maasmechelen, Belgium), J. Riley (Stevenage, United Kingdom), V. Erpenbeck (Basel, Switzerland), P. Bakke (Bergen, Norway), M. Caruso (Catania, Italy), P. Chanez (Marseille, France), S. Dahlén (Stockholm, Sweden), S. Fowler (Manchester, United Kingdom), I. Horvath (Budapest, Hungary), N. Krug (Hannover, Germany), P. Montuschi (Roma, Italy), M. Sanak (Krakow, Poland), T. Sandström (Umea, Sweden), D. Shaw (Nottingham, United Kingdom), F. Singer (Zurich, Switzerland), I. Pandis (London, United Kingdom), A. Bansal (Cambridge, United Kingdom), P. Sterk (Amsterdam, Netherlands), F. Baribaud (Springhouse, United States of America), C. Auffray (Lyon, France)
|    |
Ezrin, a membrane cytoskeleton cross linker protein, as a marker of epithelial damage in asthma X. Yao (Nanjing, China), M. Jia (Nanjing, China), X. Yan (Nanjing, China), X. Jiang (Nanjing, China), J. Jiang (Nanjing, China), X. Shan (Nanjing, China), X. Zhang (Nanjing, China), I. Adcock (London, United Kingdom), M. Huang (Nanjing, China)
|    |
Markers of systemic inflammation are associated with increased symptoms and respiratory exacerbations among smokers with preserved spirometry in SPIROMICS S. Garudadri (Cleveland, United States of America), P. Woodruff (San Francisco, United States of America), M. Han (Ann Arbor, United States of America), R. Barr (New York, United States of America), E. Bleecker (Tucson, United States of America), R. Bowler (Denver, United States of America), A. Comellas (Iowa City, United States of America), C. Cooper (Los Angeles, United States of America), G. Criner (Philadelphia, United States of America), M. Dransfield (Birmingham, United States of America), N. Hansel (Baltimore, United States of America), R. Paine (Salt Lake City, United States of America), J. Krishnan (Chicago, United States of America), S. Peters (Winston-Salem, United States of America), F. Martinez (New York, United States of America), J. Curtis (Ann Arbor, United States of America), A. Hastie (Winston-Salem, United States of America), W. O'Neal (Chapel Hill, United States of America), D. Couper (Chapel Hill, United States of America), N. Alexis (Chapel Hill, United States of America), S. Christenson (San Francisco, United States of America)
|    |
Investigating the reproducibility of real time breath measurements using proton transfer reaction - time of flight - mass spectrometry for breath of volatile organic compounds in COPD Patients. L. Bryant (Leicester, United Kingdom), L. Carr (Leicester, United Kingdom), A. Yousuf (Leicester, United Kingdom), R. Cordell (Leicester, United Kingdom), M. Wilde (Leicester, United Kingdom), C. Brightling (Leicester, United Kingdom), P. Monks (Leicester, United Kingdom)
|     |
Association between exhaled volatile organic compounds and urinary levels of oral corticosteroids within the U-BIOPRED Cohort P. Brinkman (Amsterdam, Netherlands), W. Ahmed (Manchester, United Kingdom), C. Gómez (Stockholm, Sweden), H. Knobel (Eindhoven, Netherlands), H. Weda (Eindhoven, Netherlands), T. Vink (Eindhoven, Netherlands), T. Nijsen (Eindhoven, Netherlands), C. Wheelock (Stockholm, Sweden), S. Dahlen (Stockholm, Sweden), P. Montuschi (Rome, Italy), R. Knowles (Stevenage, United Kingdom), S. Vijverberg (Amsterdam, Netherlands), A. Maitland-Van Der Zee (Amsterdam, Netherlands), P. Sterk (Amsterdam, Netherlands), S. Fowler (Manchester, United Kingdom)
|    |
Temporal Fluctuations of Electronic Nose Signatures in Patiens with Asthma and Healthy Controls Challenged With Rhinovirus A. Sinha (Amsterdam, Netherlands), R. De Vries (Amsterdam, Netherlands), J. W. F. Dagelet (Amsterdam, Netherlands), U. Frey (Basel, Switzerland), R. Lutter (Amsterdam, Netherlands), A. Maitland- Van Der Zee (Amsterdam, Netherlands), P. J. Sterk (Amsterdam, Netherlands), F. of Medicine, U. of Patras,Rion), M. Lianou (pha2306@upnet.gr / Laboratory for Molecular Respiratory Carcinogenesis, D. of Physiology, F. of Medicine, U. of Patras,Rion), V. Papaleonidopoulos (papaleonv@gmail.com / Laboratory for Molecular Respiratory Carcinogenesis, D. of Physiology, F. of Medicine, U. of Patras,Rion), G. Giotopoulou (giotopoulou.g@gmail.com / Laboratory for Molecular Respiratory Carcinogenesis, D. of Physiology, F. of Medicine, U. of Patras,Rion), K. Kauka (katerinakauka2@gmail.com / Laboratory for Molecular Respiratory Carcinogenesis, D. of Physiology, F. of Medicine, U. of Patras,Rion), I. Giopanou (giopanou@upatras.gr / Laboratory for Molecular Respiratory Carcinogenesis, D. of Physiology, F. of Medicine, U. of Patras,Rion), A. Marazioti (amarazioti@upatras.gr / Laboratory for Molecular Respiratory Carcinogenesis, D. of Physiology, F. of Medicine, U. of Patras,Rion), M. Spella (magsp@upatras.gr / Laboratory for Molecular Respiratory Carcinogenesis, D. of Physiology, F. of Medicine, U. of Patras,Rion), I. Lilis (ioannislilis@upatras.gr / Laboratory for Molecular Respiratory Carcinogenesis, D. of Physiology, F. of Medicine, U. of Patras,Rion), G. Stathopoulos (gstathop@upatras.gr / Laboratory for Molecular Respiratory Carcinogenesis, D. of Physiology, F. of Medicine, U. of Patras, C. Pneumology Center, H. Zentrum München, M. of the German Center for Lung Research (DZL) ,Rion)
|    |
Searching for inflammatory and oxidative-stress markers capable of clustering severe asthma. G. Scioscia (FOGGIA, Italy), G. Carpagnano (FOGGIA, Italy), D. Lacedonia (FOGGIA, Italy), G. Cotugno (FOGGIA, Italy), S. Santamaria (FOGGIA, Italy), M. Venuti (FOGGIA, Italy), A. Depalo (FOGGIA, Italy), M. Colanardi (FOGGIA, Italy), M. Foschino Barbaro (FOGGIA, Italy)
|     |